Latest Breaking News On - Hannah cubberley - Page 1 : comparemela.com

/PRNewswire/ Dewpoint Therapeutics, Inc., the biomolecular condensates company, today announced the completion of a $150 million Series C financing. The.

United statesJuergen eckhardtVikas parekhHannah cubberleySharon klahreMorgan warnersSoftbank vision fundPrnewswire dewpoint therapeutics incGeneral catalystMubadala capitalMirae asset capitalPolaris partnersSamsara biocapitalAmeet nathwaniDewpoint chief executiveManaging partner